Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 0.0988
March 31, 2026 0.1108
December 31, 2025 0.0912
September 30, 2025 0.0099
June 30, 2025 0.0151
March 31, 2025 0.0148
December 31, 2024 0.0024
September 30, 2024 0.0023
June 30, 2024 0.005
March 31, 2024 0.0897
December 31, 2023 0.2295
September 30, 2023 0.0705
June 30, 2023 0.4554
March 31, 2023 0.2377
December 31, 2022 0.3223
September 30, 2022 -0.1297
June 30, 2022 -0.0333
March 31, 2022 -0.0799
December 31, 2021 -0.1317
September 30, 2021 -0.056
June 30, 2021 0.0367
March 31, 2021 0.0285
Date Value
December 31, 2020 -0.2382
September 30, 2020 0.0075
June 30, 2020 -6.879
March 31, 2020 1.092
December 31, 2019 0.3475
September 30, 2019 0.6672
June 30, 2019 0.7264
March 31, 2019 0.8022
December 31, 2018 0.057
September 30, 2018 0.00
June 30, 2018 0.037
March 31, 2018 0.2873
December 31, 2017 0.1525
September 30, 2017 0.1202
June 30, 2017 0.1445
March 31, 2017 0.053
December 31, 2016 0.0483
September 30, 2016 -0.8032
June 30, 2016 -1.001
March 31, 2016 -1.377
December 31, 2015 -1.812

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 0.0413
Alnylam Pharmaceuticals, Inc. 0.8316
Anika Therapeutics, Inc. 0.1839
Savara, Inc. 0.2117
Vericel Corp. 0.2556